An Updated Contextual Approach to Mesothelial Proliferations in Pleural Effusion Cytology Leveraging Morphology, Ancillary Studies, and Novel Biomarkers

Introduction to Pleural Effusions

  • Context: Pleural effusions are common cytologic specimens used for diagnosing malignancy, which aids in patient management.

  • Diagnostic Challenges: Overlapping morphological features of reactive mesothelial proliferations, mesotheliomas, and adenocarcinomas can lead to diagnostic pitfalls.

Objectives and Conclusions

  • Objective: Review the morphologic spectrum of mesothelial proliferations in pleural effusions and relevant ancillary studies.

  • Conclusions: Knowledge of overlapping features and appropriate studies can enhance diagnostic accuracy, potentially improving outcomes for mesothelioma patients.

Etiologies of Pleural Effusions

  • Non-neoplastic Causes: Volume overload from heart/kidney failure, infections, autoimmune diseases, trauma, and infarction.

  • Malignancy Concern: Evaluation of pleural effusions often involves the risk of identifying undiagnosed malignancies.

  • Clinical Utility: A definitive malignant diagnosis can reduce reliance on invasive procedures (e.g., biopsies) and allow for better patient management strategies.

Cytologic Evaluation

  • Sensitivity Range: Pleural fluid cytology sensitivity for malignancy detection ranges from 20% to 86%, depending on tumor type and quality.

  • Comparative Sensitivity: Pleural effusions often show higher sensitivity in diagnosis compared to pleural biopsies (e.g., sensitivity of 71% vs. 45% in detecting malignant processes).

Diagnostic Difficulties with Mesothelioma

  • Challenges: Diagnosing mesothelioma via cytology is notably difficult, with sensitivity reported between 32% and 53% due to:

    1. Inability to evaluate tissue invasion.

    2. Morphologic overlap with benign findings.

    3. Variable cellularity in specimens.

  • Consequences: Overinterpretation of benign cells as malignant must be avoided; specificity is generally high (~99%).

Morphology of Mesothelial Cells

  • Histology: Mesothelial cells are usually flat, elongated, sometimes cuboidal, exhibiting granular cytoplasm and distinct nuclei.

  • Reactive Changes: Induced by irritation; can lead to hyperplasia, enlarged nuclei, and atypical features such as mitotic figures and necrosis in the background.

  • Cytologic Features: In benign conditions, mesothelial cells are low in quantity with specific cytologic characteristics (e.g., low N:C ratio).

Differential Diagnosis: Mesothelial Proliferation vs. Adenocarcinoma

  • Malignant Effusions: Most arise from metastatic adenocarcinomas, which can initially signal malignancy rather than established cancer.

  • Cytologic Characteristics: Adenocarcinomas show a biphasic population with pleomorphic malignant cells and distinct cell group morphology, contrasting with mesothelial features such as scalloped borders and variable degrees of vacuolization.

Ancillary Studies for Accurate Diagnosis

  • Importance of Ancillary Tests: To accurately differentiate between mesothelial and adenocarcinoma in ambiguous cases.

  • Immunohistochemistry (IHC): Recommend using multiple mesothelial markers (e.g., WT-1, calretinin, CK5/6).

  • Challenges in IHC: No single marker has 100% sensitivity; the combination of mesothelial markers is crucial for precision.

Morphologic Overlaps & Diagnostic Pitfalls

  • Overlapping Features: Both benign mesothelial cells and adenocarcinomas may exhibit pleomorphism and vacuolization, increasing diagnostic ambiguity.

  • Collagen Balls: Misdiagnosis can occur due to confusion with malignant clusters in certain cytological specimens (pelvic washings).

Molecular Markers and Recent Developments

  • Molecular Profiles: Mesothelioma shows distinct chromosomal alterations that differ from those in metastatic adenocarcinoma, emphasizing the need for molecular characterization in diagnostics.

  • Current Trends: Markers such as MTAP and BAP-1 are highlighted for their specificity and sensitivity in distinguishing malignant mesothelial proliferations.

Special Considerations in Mesothelioma Diagnosis

  • Prognostic Factors: Type (epithelioid, sarcomatoid) affects prognosis and influences fluid cytology detection rates.

  • Emerging Techniques: Continued research in IHC and molecular markers (e.g., 5-hmC, EZH2) enhances diagnostic utility and supports accurate categorization of mesothelial proliferations in cytology.

Conclusion

  • Understanding the spectrum of mesothelial cell proliferations improves the diagnostic process for pleural effusion cytology, helping mitigate diagnostic pitfalls via comprehensive assessments that include both morphological evaluation and molecular testing.